
Three new venture funds are seeking to invest up to $6.3 billion in start-up companies with advances in life sciences, health care, energy, and information technologies. . . . → Read More: New Venture Funds to Back Life Science, Tech Start-Ups
|
|||||
![]() Three new venture funds are seeking to invest up to $6.3 billion in start-up companies with advances in life sciences, health care, energy, and information technologies. . . . → Read More: New Venture Funds to Back Life Science, Tech Start-Ups ![]() Research findings show data in patients’ electronic health records can be collected and analyzed to replicate results from late-stage clinical trials of an eye disease biologic drug. . . . → Read More: Real-World Data Shown to Match Eye Disease Trial Results ![]() A vaccine against gonorrhea given as a nasal spray is shown to generate protective immune responses in lab mice of both sexes, and in females similar to an intravaginal vaccine. . . . → Read More: Nasal Spray Vaccine Shown to Stop Gonorrhea Infections ![]() Venture funds for new U.S. biotechnology and pharmaceutical companies declined from historical highs in 2022, but a closer look reveals even more signs of financial tightening. . . . → Read More: Infographic – 2022 Biotech Venture Funding Weakens ![]() An international health organization is evaluating a new type of vaccine made with biodegradable RNA nanoparticles to help head off future viral pandemics. . . . → Read More: CEPI Assessing Advanced RNA Nanoparticle Vaccine ![]() A bioengineering team devised techniques for feasibly adding cancer-killing enzymes to engineered immune cells that in lab mice kill solid-tumor and blood cancer cells. . . . → Read More: Nanotech Enzyme Process Boosts T-Cell Cancer Therapies ![]() The biotechnology company BioNTech SE is partnering with the U.K. government to provide up to 10,000 personalized cancer immunotherapy treatments by 2030. . . . → Read More: BioNTech to Provide Personal Cancer Immunotherapies in UK ![]() A partnership of biotechnology components and therapy companies aims to develop new drugs made from circular forms of RNA, starting with a colorectal cancer treatment. . . . → Read More: Biotech Alliance Creating Circular RNA Cancer Drug ![]() An enterprise discovering new drugs with optical light-based protein chemistry is emerging from stealth, including work with biopharmaceutical company Genentech. . . . → Read More: Protein Chemistry Biotech Gains Collaboration, Venture Funds ![]() Findings from a clinical trial show an anti-inflammatory drug reduces new symptoms among people with Covid-19 infections and keeps them out of the hospital. . . . → Read More: Trial Shows Anti-Inflammatory Drug Stops Covid-19 Hospitalization |
|||||
Copyright © 2023 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |